| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. (VIR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. VIR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.73M | $139.49M | - | |
| Dir | 1.10M | $11.18M | - | |
| CEO | 714.6K | $7.26M | - | |
| CFO | 160.1K | $1.63M | - | |
| VP | 104.6K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2020 | Horn Howard81 | CFO | Sell | 10,000 | $40.00 | $400,000.00 | -3.7% | |
| Jun 19, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,510 | $38.00 | $133,384.04 | -66.7% | |
| Jun 17, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $37.27 | $465,814.50 | -24.2% | |
| Jun 9, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,805 | $36.28 | $138,030.18 | -100% | |
| Jun 3, 2020 | Pang Phillip80 | Chief Medical Officer | Sale+OE | 12,500 | $35.07 | $438,387.00 | -24.2% | |
| Jun 1, 2020 | Horn Howard81 | CFO | Sell | 10,000 | $35.10 | $351,038.13 | -1.8% | |
| Jun 1, 2020 | Parrish Jay | Chief Business Officer | Sale+OE | 75,000 | $35.22 | $2,641,410.00 | -25.2% | |
| May 26, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,805 | $34.08 | $129,674.40 | -100% | |
| May 18, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 1,755 | $38.00 | $66,690.00 | -100% | |
| May 14, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,805 | $30.07 | $114,418.25 | -100% |